Latest Breaking News On - Phenomix sciences - Page 7 : comparemela.com
Phenomix Sciences Announces First Precision Obesity Biobanking Registry and Outcomes Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Health2047 launches RecoverX to empower physicians with evidence-based augmented intelligence
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Phenomix Inks Licensing Deal with Mayo Clinic for Obesity Phenotype Blood Test
What You Should Know:
– Today, Phenomix Sciences announced the company has signed an exclusive technology licensing agreement with Mayo Clinic for a novel blood test that accurately predicts obesity phenotypes.
– The multi-level “omics” MyPhenome™ test leverages technology developed at Mayo Clinic to analyze genomics, metabolomics and hormone levels. Its AI-driven algorithmic solution identifies four specific obesity phenotypes to give doctors the ability to prescribe more precise anti-obesity treatments.
– With the finalization of the CLIA lab underway, Phenomix anticipates launching the MyPhenome™ test before the end of 2021.
Guiding Treatment by Four Obesity Phenotypes
Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices
What You Should Know:
– Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patients to participate in clinical research.
– SiteBridge Research creates a network of independent, small practice physicians to gather data from a broader, more inclusive patient population and, ultimately, create more widely applicable clinical trial results.
– SiteBridge’s executive team taps both physician and pharma industry perspectives. The company was founded by Manesh R. Patel, M.D., chief of the division of Cardiology and division of Clinical Pharmacology at Duke University School of Medicine. The chief executive officer is Chris Komelasky, formerly an executive at PPD, a global pharmaceutical contract
Health2047 Spins Out Emergence Healthcare Group to Empower Independent Physician Practices
digitalfacility.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitalfacility.com Daily Mail and Mail on Sunday newspapers.